Figure 3. Clinical characteristics of m5C regulators in acute myeloid leukemia (AML). Expression of m5C regulators between (A) age groups, (B) CR groups, (C) FAB groups, (D) male and female, (E) survival status, and (F) before and after treatment in AML patients. *p < 0.05, **p < 0.01, ***p < 0.001.